Association of glutathione S-transferase gene (M1/P1) polymorphism and oxidative stress level with bladder cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049685

Enrollment

Unknown

Registered

2021-08-08

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

case group:None

control group:None

Eligibility

Sex/Gender

Male

Age

32 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Bladder cancer patients who visited the Department of Urology, Affiliated Hospital of Guizhou Medical University from August 2021 to December 2021. 2. Inform the experimental content and sign the relevant informed consent. 3. Exclude hematuria diseases caused by other diseases, such as urinary calculi, renal tuberculosis, renal cancer, acute appendicitis, etc.. 4. Laboratory examinations: urine routine, urine exfoliated cell examination, etc.; imaging examinations: urinary ultrasound, cystoscopy, photodynamic examinations, etc. to diagnose patients with bladder cancer.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
xanthine oxidase;malondialdehyde;nitric oxide;glutathione peroxidase;reduced glutathione;glutathione S-transferase gene (M1/T1/P1);	—

Countries

China

Contacts

Public ContactTang Kaifa

The Affiliated Hospital of Guizhou Medical University

tangkaifa@gmc.edu.cn+86 15285182092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026